| Literature DB >> 34811383 |
Cosimo Chelazzi1, Gianluca Villa1,2, Andrea Manno3, Viola Ranfagni2, Eleonora Gemmi2, Stefano Romagnoli1,2.
Abstract
An accurate assessment of preoperative risk may improve use of hospital resources and reduce morbidity and mortality in high-risk surgical patients. This study aims at implementing an automated surgical risk calculator based on Artificial Neural Network technology to identify patients at risk for postoperative complications. We developed the new SUMPOT based on risk factors previously used in other scoring systems and tested it in a cohort of 560 surgical patients undergoing elective or emergency procedures and subsequently admitted to intensive care units, high-dependency units or standard wards. The whole dataset was divided into a training set, to train the predictive model, and a testing set, to assess generalization performance. The effectiveness of the Artificial Neural Network is a measure of the accuracy in detecting those patients who will develop postoperative complications. A total of 560 surgical patients entered the analysis. Among them, 77 patients (13.7%) suffered from one or more postoperative complications (PoCs), while 483 patients (86.3%) did not. The trained Artificial Neural Network returned an average classification accuracy of 90% in the testing set. Specifically, classification accuracy was 90.2% in the control group (46 patients out of 51 were correctly classified) and 88.9% in the PoC group (8 patients out of 9 were correctly classified). The Artificial Neural Network showed good performance in predicting presence/absence of postoperative complications, suggesting its potential value for perioperative management of surgical patients. Further clinical studies are required to confirm its applicability in routine clinical practice.Entities:
Mesh:
Year: 2021 PMID: 34811383 PMCID: PMC8608915 DOI: 10.1038/s41598-021-01913-z
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
The considered risk factors.
| 1. Abnormal ECG (left bundle branch block, left ventricular hypertrophy, repolarization abnormalities, non-sinus rhythm) | |
| 2. Untreated hypertension or hypertension not controlled by medical therapy | |
| 3. Previous thromboembolism | |
| 4. Stable or controlled angina | |
| 5. Previous myocardial infarction with no clinical or diagnostic evidence of residual ischemia | |
| 6. Compensated heart failure or previous heart failure | |
| 7. Diabetes mellitus | |
| 8. Neoplastic disease | |
| 9. Transfusion in the preoperative period (> 4 units) | |
| 10. Smoking and/or drug addiction | |
| 11. BMI > 25 or < 17 weight loss>10% in the preoperative period, plasma proteins < 7 g/dl | |
| 12. Creatinine > 3.5 g/dl | |
| 13. Steroid use | |
| 14. Prevision of prolonged surgery (reoperation, anatomical abnormalities, etc.) | |
| 15. History of COPD/dyspnea | |
| 16. Decompensated heart failure | |
| 17. Valve disease | |
| 18. Severe arrhythmias: advanced AV block (second-degree block, Mobitz 2 > 2:1, block grade III) | |
| Symptomatic ventricular arrhythmias, supraventricular arrhythmias with uncontrolled ventricular response | |
| 19. Breast surgery | |
| 20. Dental surgery | |
| 21. Endocrine surgery (no pheochromocytoma) | |
| 22. Eye surgery | |
| 23. Gynecological surgery | |
| 24. Reconstructive surgery | |
| 25. Minor orthopedic surgery (other than hip and spine) | |
| 26. Minor urological surgery | |
| 27. Abdominal surgery | |
| 28. Carotid surgery | |
| 29. Head and neck surgery | |
| 30. Neurologic/orthopedic (hip and spine) surgery | |
| 31. Lung/kidney transplant | |
| 32. Major urological surgery | |
| 33. Endocrine surgery (pheochromocytoma) | |
| 34. Peripheral vascular surgery | |
| 35. Aortic and major vascular surgery | |
| 36. Pancreas/liver surgery | |
| 37. Emergency abdominal surgery | |
| 38. Open surgery | |
| 39. Laparoscopic surgery | |
| 40. Robotic surgery | |
| 41. Endoscopic surgery |
Distribution of risk factors in the control group and the Pocs group.
| Risk factors | Total | Control group (Clavien-Dindo | Pocs group (Clavien-Dindo > 1) |
|---|---|---|---|
| Abnormal ECG | 188 | 168 (89.4%) | 20 (10.6%) |
| Previous thromboembolism | 17 | 16 (94.1%) | 1 (5.1%) |
| Untreated hypertension or hypertension therapy | 247 | 227(91.9%) | 20 (8.1%) |
| Previous myocardial infarction without residual ischemia | 26 | 26 (100%) | 0 (0%) |
| Stable or controlled angina | 21 | 19 (90.5%) | 2(9.5%) |
| Compensated heart failure or previous heart failure | 21 | 20 (95.2%) | 1(4.5%) |
| Diabetes mellitus | 64 | 57 (89%) | 7(11%) |
| Neoplasticdisease | 308 | 277(89.9%) | 31(10.1%) |
| Transfusion in pre-operative period (> 4 units) | 9 | 7 (77.7%) | 2(22.3%) |
| Previous transient ischemic attack (TIA)/stroke | 22 | 21 (95.5%) | 1(4.5%) |
| Smoking addiction and/or drug addiction | 180 | 165 (91.6%) | 15 (8.4%) |
| BMI > 25/< 18, weight loss > 10%, plasma proteins < 7 g/dl | 277 | 255 (92%) | 22 (8%) |
| Creatinine > 1.5 mg/dl | 45 | 41 (91%) | 4 (9%) |
| Steroid use | 29 | 25 (86%) | 4 (14%) |
| Prevision of prolonged surgery | 12 | 8 (66.6%) | 4 (33.4%) |
| History of COPD/dyspnea | 99 | 89 (89.9%) | 10 (10.1%) |
| Decompensated heart failure | 2 | 1 (50%) | 1 (50%) |
| Symptomatic valvular disease | 0 | 0 | 0 |
| Severearrhythmias: | 0 | 0 | 0 |
| Endocrine surgery (no pheochromocytoma) | 1 | 1 (100%) | 0 (0%) |
| Gynecological surgery | 4 | 3 (75%) | 1 (25%) |
| Minor urological surgery | 158 | 153 (96.8%) | 5 (3.2%) |
| Abdominal surgery | 249 | 223 (89.5%) | 26 (10.5%) |
| Thoracic surgery | 1 | 1(100%) | 0 (0%) |
| Head and neck surgery | 11 | 11(100%) | 0 (0%) |
| Lung/kidney transplant | 1 | 1 (100%) | 0 (0%) |
| Mayor urological surgery | 74 | 68(91.9%) | 6 (8.1%) |
| Pheochromocytoma | 1 | 1 (100%) | 0 (0%) |
| Pancreas/liversurgery | 24 | 19 (79.2%) | 5 (20.8%) |
| Emergency abdominal surgery | 2 | 0 (0%) | 2(100%) |
| Open surgery | 142 | 125 (88%) | 17(22%) |
| laparoscopic surgery | 143 | 132 (92.3%) | 11(7.7%) |
| Robotic surgery | 89 | 81 (91%) | 8(9%) |
| Endoscopicsurgery | 152 | 146 (96.7%) | 6(3.3%) |
For layout reasons, some risk factors descriptions have been abbreviated with respect to Table 1.
Clavien scores.
| Grade | Definition |
|---|---|
| Grade I | Any deviation from the normal postoperative course without the need for pharmacological treatment, or surgical, endoscopic, or radiological procedures. Permitted therapeutic regimens: drugs and antiemetics, antipyretics, analgesics, diuretics, electrolytes, and physiotherapy. This grade also includes wound infections opened at the bedside |
| Grade II | Requiring pharmacological treatment with drugs other than those permitted for grade I complications |
| Grade III | Requiring surgical, endoscopic, or radiological procedures. Grade IIIa: procedure not under general anesthesia Grade IIIb: procedure under general anesthesia |
| Grade IV | Life-threatening complications (including central nervous system complications) requiring IC/ICU management. Grade IVa: single-organ dysfunction (including dialysis) Grade IVb: multiorgan dysfunction |
| Grade V | Death |
Distribution of complications among patients, according to the Clavien-Dindo classification.
| Clavien score | Number of cases |
|---|---|
| 0–1 | 483 (91.8%) |
| 2 | 25 (4.7%) |
| 3 | 12 (2.3%) |
| 4 | 3 (0.6%) |
| 5 | 3 (0.6%) |
Distribution of the Clavien-Dindo score among patients, according to the ASA score.
| ASA score | Clavien-Dindo score | |
|---|---|---|
| > 1 | ||
| 1 | 66 (94.3%) | 4 (5.7%) |
| 2 | 294 (93.3%) | 921 (6.7%) |
| 3 | 118 (87.4%) | 17 (12.6%) |
| 4 | 5 (83.3%) | 1 (16.7%) |
| 5 | 0 | 0 |
Distribution of patients in the training set and the testing set.
| Training set | Testing set | |
|---|---|---|
| Patients from the control group | 432 | 51 |
| Patients from the PoCs group | 68 | 9 |
| Total | 500 | 60 |
Figure 1ROC-AUC analysis for the SLFN and DT models.